检索

期
标题
作者
卷 96, 编号 4 (2024): Issues of diagnostics of internal diseases
The clinician's view on the advantages and contradictions of the new nomenclature of steatotic liver disease: A review
Pavlov C., Teplyuk D., Lazebnik L., Ametov A., Pashkova E., Sorokoletov S., Uspenskiy Y., Turkina S., Ponomarenko E., Maslakov A.
PDF
(Rus)
卷 93, 编号 4 (2021)
Mixed steatohepatitis: more questions than answers (part 2)
Raikhelson K., Kondrashina E., Pazenko E.
PDF
(Rus)
卷 91, 编号 12 (2019)
Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features
Kalmykova Z., Kononenko I., Mayorov A.
PDF
(Rus)
卷 91, 编号 10 (2019)
Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis
Kalmykova Z., Kononenko I., Mayorov A.
PDF
(Rus)
卷 94, 编号 12 (2022)
Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions
Toktogulova N., Sultanalieva R., Tuhvatshin R., Kaliev T.
PDF
(Rus)
卷 93, 编号 8 (2021)
Obesity as a risk factor for diseases of the digestive system
Andreev D., Kucheryavyy Y.
PDF
(Rus)
卷 96, 编号 8 (2024): Treatment issues
The relationship between diabetes mellitus and non-alcoholic fatty liver disease: a clinical and instrumental paired study
Sasunova A., Goncharov A., Gapparova K., Isakov V.
PDF
(Rus)
卷 95, 编号 10 (2023)
Non-alcoholic fatty liver disease: aspects of management of a comorbid patient. A review
Demidova T., Ushanova F.
PDF
(Rus)
卷 92, 编号 12 (2020)
Mixed steatohepatitis: more questions than answers (Part 1)
Raikhelson K., Kondrashina E., Pazenko E.
PDF
(Rus)
卷 92, 编号 8 (2020)
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics
Anisonyan A., Sandler Y., Khaimenova T., Keyan V., Saliev K., Sbikina E., Vinnitskaya E.
PDF
(Rus)
卷 92, 编号 8 (2020)
Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease
Cherkashchenko N., Livzan M., Krolevets T.
PDF
(Rus)
卷 92, 编号 2 (2020)
Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease
Cherkashchenko N., Livzan M., Krolevets T.
PDF
(Rus)
卷 91, 编号 2 (2019)
Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis
Vakhrushev Y., Lukashevich A., Penkina I., Suchkova E.
PDF
(Rus)
卷 89, 编号 1 (2017)
Involvement of the hepatobiliary system and pancreas in obesity
Akhmedov V., Gaus O.
PDF
(Rus)
卷 89, 编号 2 (2017)
Features of a necrotic and inflammatory process in different forms of nonalcoholic fatty liver disease
Kurbatova I., Dudanova O.
PDF
(Rus)
卷 95, 编号 8 (2023)
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
PDF
(Rus)
卷 94, 编号 2 (2022)
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M., Kotovskaya Y., Ivashkin V., Tkacheva O., Troshina E., Shestakova M., Breder V., Geyvandova N., Doshchitsin V., Dudinskaya E., Ershova E., Kodzoeva K., Komshilova K., Korochanskaya N., Mayorov A., Mishina E., Nadinskaya M., Nikitin I., Pogosova N., Tarzimanova A., Shamkhalova M.
PDF
(Rus)
卷 94, 编号 12 (2022)
Subclinical markers of liver damage in patients with arterial hypertension and obesity
Sadulaeva I., Yushchuk E., Khalikova L., Krikunova O., Trofimenko O., Medvedeva E.
PDF
(Rus)
卷 95, 编号 8 (2023)
Assessment of body mass index in patients with chronic hepatitis C who received an effective antiviral therapy
Dudina K., Belyy P., Maev I., Klimova E., Shutko S., Znoyko O., Yuschuk N.
PDF
(Rus)
卷 91, 编号 4 (2019)
Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis
Kurbatova I., Topchieva L., Dudanova O., Shipovskaya A.
PDF
(Rus)
卷 91, 编号 2 (2019)
Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease
Akhmedov V., Gaus O.
PDF
(Rus)
卷 96, 编号 12 (2024): VARIO (РАЗНОЕ)
Non-alcoholic fatty liver disease and cognitive impairment
Onuchina E., Dambaeva B., Glazunova A., Mikhailova A., Vorobyova E., Soshina E., Efremenko N.
PDF
(Rus)
卷 91, 编号 2 (2019)
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy
Maevskaya M., Ivashkin V., Ivashkin K., Lunkov V., Liusina E., Zozula V., Leshchenko V.
PDF
(Rus)
卷 89, 编号 10 (2017)
CYP7A1 gene polymorphism and the characteristics of dyslipidemias in patients with nonalcoholic fatty liver disease concurrent with hypothyroidism
Zhaldak D., Melekhovets O., Orlovskyi V.
PDF
(Rus)
卷 88, 编号 2 (2016)
Evaluation of the efficiency of hepatoprotective monotherapy using succinic acid and methionine for nonalcoholic fatty liver disease at the stage of steatohepatitis
Semiserin V., Karakozov A., Malkuta M., Zolotareva L., Levchenko O., Kalyagin I., Eremin M.
PDF
(Rus)
卷 94, 编号 10 (2022)
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy
Petunina N., Telnova M., Goncharova E., Martirosian N., Kuzina I.
PDF
(Rus)
卷 87, 编号 5 (2015)
Evaluation of endothelial function and estimation of the degree of apoptosis in patients with metabolic syndrome and non-alcoholic fatty liver disease
Drapkina O., Deeva T., Ivashkin V.
卷 94, 编号 2 (2022)
The study of abdominal and parietal enteric microbiota in patients with non-alcoholic fatty liver disease
Vakhrushev Y., Lukashevich A., Lyapina M.
PDF
(Rus)
卷 93, 编号 2 (2021)
The importance of the bacterial overgrowth syndrome in the development of disorders metabolic functions of the liver in non-alcoholic fatty liver disease
Vakhrushev Y., Lukashevich A.
PDF
(Rus)
卷 86, 编号 10 (2014)
Current approaches to diagnosing and treating nonalcoholic fatty liver disease
Drapkina O., Deeva T., Volkova N., Ivashkin V.
卷 91, 编号 12 (2019)
Peculiarities of heart risk in patients with non - alcoholic fatial liver disease
Mosina L., Stolyarova V., Esina M., Titojkina Y., Korobkov D.
PDF
(Rus)
卷 90, 编号 2 (2018)
Intrahepatic cholestasis in nonalcoholic fatty liver disease
Shipovskaya A., Dudanova O.
PDF
(Rus)
卷 95, 编号 8 (2023)
Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease
Goncharov A., Sasunova A., Pilipenko V., Isakov V.
PDF
(Rus)
卷 88, 编号 12 (2016)
The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease
Livzan M., Akhmedov V., Krolevets T., Gaus O., Cherkaschenko N.
PDF
(Rus)
卷 84, 编号 6 (2012)
CLINICOPATHOGENETIC CHARACTERISTICS OF CARDIORENAL SYNDROME IN NON-ALCOHOLIC FATTY DISEASE OF THE LIVER
Severova M., Saginova E., Gallyamov M., Ermakov N., Rodina A., Fomin V., Mukhin N.
卷 88, 编号 9 (2016)
Nonalcoholic steatohepatitis and biliary sludge in people with metabolic syndrome
Radchenko V., Seliverstov P., Ledentsova S., Manyakov A.
PDF
(Rus)
卷 82, 编号 6 (2010)
Association of obstructive sleep apnea syndrome with the signs of non-alcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome
Severova M., Fomin V., Lebedeva M., Sorokin Y., Saginova E., Minakova E., Gallyamov M., Mukhin N.
1 - 37 的 37 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语